Prashant Kohli
Chief Executive Officer bij ACASTI PHARMA INC.
Vermogen: 73 148 $ op 31-03-2024
Profiel
Prashant Kohli is currently the Chief Executive Officer & Director at Acasti Pharma, Inc. He previously worked as the Vice President-Commercial Operations at Grace Therapeutics LLC.
Mr. Kohli completed his undergraduate degree at Augustana College (Illinois) and holds undergraduate and MBA degrees from The Wharton School of the University of Pennsylvania.
Bekende belangen in openbare bedrijven
Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
---|---|---|---|---|
19-12-2023 | 21 357 ( 0.23% ) | 73 148 $ | 31-03-2024 |
Actieve functies van Prashant Kohli
Bedrijven | Functie | Begin |
---|---|---|
ACASTI PHARMA INC. | Chief Executive Officer | 04-04-2023 |
Eerdere bekende functies van Prashant Kohli
Bedrijven | Functie | Einde |
---|---|---|
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Corporate Officer/Principal | 01-08-2021 |
Opleiding van Prashant Kohli
Augustana College (Illinois) | Undergraduate Degree |
The Wharton School of the University of Pennsylvania | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ACASTI PHARMA INC. | Health Technology |
Bedrijven in privébezit | 1 |
---|---|
Grace Therapeutics LLC
Grace Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Part of Acasti Pharma, Inc., Grace Therapeutics LLC is a private company that designs and develops drug delivery technology and products. The company is based in East Brunswick, NJ. The company was founded in 2014 by Vimal Kumar Kavuru, Santosh George Kottayil. Grace Therapeutics was acquired by Acasti Pharma, Inc. on August 27, 2021 for $63.41 million. | Commercial Services |